Connect with us

Hi, what are you looking for?

POZ

78% not open to dating someone HIV-positive, survey finds

At least in the US, only 6% say they would be open to having a relationship with an HIV-positive individual, while 78% of the respondents said they were not open to it and 16% said they were undecided. Of these, more men than women (8% versus 5%) were open to a relationship with an HIV-positive partner, while 19% of the women versus 13% of the men were unsure.

At least in the US, only 6% say they would be open to having a relationship with an HIV-positive individual, while 78% of the respondents said they were not open to it and 16% said they were undecided.

Of these, more men than women (8% versus 5%) were open to a relationship with an HIV-positive partner, while 19% of the women versus 13% of the men were unsure.

These were the findings of a survey done by adamandeve.com, source for adult products in the US. This time, the company asked over 1,000 adults if they would be open to having a relationship with someone who is HIV positive.

“HIV, or the human immunodeficiency virus, is a sexually transmitted infection that, if left untreated, can cause AIDS,” said Dr. Kat Van Kirk of adamandeve.com. “With around 1.2 million Americans now living with HIV, and advances in medical treatment, you would think that the virus would lose much of the stigma it had for so many years. Many couples that include one HIV positive partner (sero-discordant) compare it to living with any other chronic disease with the successful use of safer sex practices.”

The web-based survey, conducted by an independent third party survey company, of over 1,000 American adults age 18 and up, was sponsored by adamandeve.com to study sexual preferences and practices.

Advertisement
Advertisement

Like Us On Facebook

YOU MAY ALSO LIKE

POZ

With the new pill, most participants experienced fewer lipid-related side effects, such as increased cholesterol levels, suggesting an additional potential benefit for those at risk of heart...

POZ

The medication, anifrolumab, blocks type 1 interferon and is used to treat systemic lupus erythematosus, SLE, an autoimmune disease.

POZ

Developing an intermittent treatment relieves the need for daily pills and, given that no medicine is needed at home, directly addresses the stigma that...

POZ

The probability of being employed declines by 4%, work hours decrease by 5%, and income declines by 9% after HIV diagnosis. HIV also leads...

Advertisement